Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...

President Donald Trump signed an executive order Thursday to expedite the reclassification of marijuana – an effort to increase research on its medical use but not fully legalize it. “This ...

Fluorine is critical for biomedicine. This element can help drug compounds be more potent and last longer in the body, and its radioactive isotope, fluorine-18, powers medical imaging techniques such ...

WASHINGTON – President Donald Trump and his top aides have justified lethal military strikes on suspected drug smuggling boats from Venezuela by accusing Venezuela and suspected criminal networks ...

The first comprehensive assessment of how drug use affects transit in five U.S. cities found that transit workers are being forced to become de facto public health responders and exposure to overdoses ...

In case you've faced some hurdles solving the clue, Twelve-step program for friends and relatives, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, ...

Mark Cuban (center), co-founder of Cost Plus Drugs explains his company's discussions with Humana to develop "direct-to-employer" prescription drug programs that bypass traditional pharmacy benefit ...

A former senior Drug Enforcement Administration (DEA) official and an associate have been charged with conspiring to launder millions of dollars and provide support to a Mexican drug cartel, an ...

Groceries, medications, new shoes, electric bills: many Central Valley families face impossible choices. Prescription drugs should not be on that list. The federal 340B prescription drug pricing ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...

Dr. Richard Pazdur will retire after 26 years at the FDA He was the fourth person to lead the Center for Drug Evaluation and Research (CDER) Experts warn that ongoing departures could weaken ...

The FDA White Oak Campus, headquarters of the U.S. Food and Drug Administration Dr. Richard Pazdur will retire after 26 years at the FDA He was the fourth person to lead the Center for Drug Evaluation ...